Resultados de procura - Ingeborg B. Engelsen
- Mostrando 1 - 3 Resultados de 3
-
1
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome por Camilla Krakstad, Jone Trovik, Elisabeth Wik, Ingeborg B. Engelsen, Henrica M.J. Werner, Einar Birkeland, Maria B. Ræder, Anne M. Øyan, Ingunn M. Stefansson, Karl H. Kalland, Lars A. Akslen, Helga B. Salvesen
Publicado 2012Artigo -
2
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation por Helga B. Salvesen, Scott L.b Carter, Monica Mannelqvist, Amit Dutt, Gad Getz, Ingunn M. Stefansson, Maria B. Ræder, Martin L. Sos, Ingeborg B. Engelsen, Jone Trovik, Elisabeth Wik, Heidi Greulich, Trond Hellem Bø, Inge Jonassen, Roman K. Thomas, Thomas Zander, Levi A. Garraway, Anne M. Øyan, William R. Sellers, Karl‐Henning Kalland, Matthew Meyerson, Lars A. Akslen, Rameen Beroukhim
Publicado 2009Artigo -
3
Drug-sensitive<i>FGFR2</i>mutations in endometrial carcinoma por Amit Dutt, Helga B. Salvesen, Tzu-Hsiu Chen, Alex H. Ramos, Robert C. Onofrio, Charlie Hatton, Richard Nicoletti, Wendy Winckler, Rupinder Grewal, Megan Hanna, Nicolas Wyhs, Liuda Ziaugra, Daniel J. Richter, Jone Trovik, Ingeborg B. Engelsen, Ingunn M. Stefansson, Tim Fennell, Kristian Cibulskis, Michael C. Zody, Lars A. Akslen, Stacey B. Gabriel, Kwok‐Kin Wong, William R. Sellers, Matthew Meyerson, Heidi Greulich
Publicado 2008Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Cancer research
Cancer
Carcinoma
Endometrial cancer
Gene
Genetics
Internal medicine
Medicine
Oncology
Allele
Breast cancer
Cell cycle
Drug
Estrogen receptor
GPER
Gene duplication
Gene expression
Gene expression profiling
Loss of heterozygosity
Mutation
Oncogene
PI3K/AKT/mTOR pathway
PTEN
Pharmacology
Phenotype
Signal transduction